• Profile
Close

Chemoradiation for high-grade neuroendocrine carcinoma of the rectum and anal canal

American Journal of Clinical Oncology Dec 14, 2017

Voong KR, et al. - Outcomes in patients with high-grade neuroendocrine (HGNE) carcinoma of the anorectum treated with pelvic chemoradiation were evaluated in this study. For the majority of the patients’ lifetime, pelvic chemoradiation provided locoregional control (LRC). Although patterns of distant failure did not support routine prophylactic cranial irradiation, most patients had a distant failure.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay